OUR BUSINESS
Breckenridge is positioned 1st or 2nd across 70% of our portfolio
Since 1983, Breckenridge has been dedicated to a mission: to lead the American market in the therapeutic areas where we are present. Breckenridge was founded with the purposes of bringing affordable medications to patients and equitable access to for all.
In addition to marketing generic medications, we built a partnership model creating opportunities that maximize the benefit we offer to the healthcare community.
With an experienced team throughout the organization, we commercialize a diverse line of products including authorized generics, ANDAs (abbreviated new drug applications), and medical foods, with more than 1.2 billion doses dispensed in the past 12 months.
But beyond numbers and figures, our true purpose lies in something deeper: products with purpose and products that meet the current needs of patients. Our journey continues as we add strategically significant products to our portfolio.
At Breckenridge, we believe that our ikigai, our reason for being, is to contribute to people’s health and generate genuine smiles. Because for us, it’s not just about medications: it’s about providing equitable access to affordable and high-quality medications.
Driven by our commitment to health equity and patient well-being, our vision is to become the leading US provider of generic pharmaceuticals
Near-Term
Continue to add differentiated products via alternate dosage forms and therapeutic categories.
Mid-Term
Expand our portfolio by adding sterile liquids, fill forms, and complex generics.
Long-Term
Pursue differentiated specialty drug delivery platforms. Ex. 505(b)2